Skip to content

Systemic and local oxidative stress in COPD

Systemic and local oxidative post-translational modification â?? S-glutathionylation in COPD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/04/018511
Enrollment
50
Registered
2019-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

None listed

Sponsors

Chest Research Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy non-smoker Be at least 40 years of age Provide written informed consent Never smoker and not exposed to biomass for >10 years No major abnormality on clinical examination Normal spirometry, FEV1/FVC >0.70 (or IOS 80-120% predicted if not able to perform Spirometry) FEF25-75 > 65% DLCO >= 80% predicted Body plethysmography TLC >= 80% predicted Healthy smoker Be at least 40 years of age Provide written informed consent Be smoking tobacco in the form of bidi or cigarettes for at least 10 pack years No major abnormality on clinical examination Normal spirometry, FEV1/FVC >0.70 (or IOS 80-120% predicted if not able to perform Spirometry) FEF25-75 > 65% DLCO >= 80% predicted Body plethysmography TLC >= 80% predicted Healthy Biomass user Be at least 40 years of age Provide written informed consent Be exposed to biomass for at least 10 fuel-years (women)/ 20 fuel-years (men) (exposure of 2hrs/day for 10 years) after adulthood No major abnormality on clinical examination Normal spirometry, FEV1/FVC >0.70 (or IOS 80-120% predicted if not able to perform Spirometry) FEF25-75 > 65% DLCO >= 80% predicted Body plethysmography TLC >= 80% predicted Tobacco smoking COPD Be at least 40 years of age Provide written informed consent Be smoking tobacco in the form or bidi or cigarettes for at least 10 pack-years Have a clinical diagnosis of COPD (GOLD stage I to III) and post-bronchodilator FEV1/FVC ratio 1500 % predicted if not able to perform Spirometry) DLCO Body plethysmography TLC Non-smoking COPD Be at least 40 years of age Provide written informed consent Be exposed to biomass for at least 10 fuel-years (women)/ 20 fuel-years (men) after adulthood Have a clinical diagnosis of COPD (GOLD stage I to III): post-bronchodilator FEV1/FVC ratio 1500 % predicted if not able to perform Spirometry)) DLCO Body plethysmography TLC Never smoker FEV1 reversibility

Exclusion criteria

Exclusion criteria: Subjects suffering from comorbidities such as diabetes. Very Severe COPD patients would be excluded as the process of sputum induction may worsen their condition History of lung condition other than COPD including respiratory infectious diseases like tuberculosis, asthma, interstitial lung disease, etc

Design outcomes

Primary

MeasureTime frame
Identification of proteins modified by oxidative post translational modification in COPD patientsTimepoint: Not applicable as this is an observational study and does not involve an intervention.

Secondary

MeasureTime frame
NoneTimepoint: 1

Countries

India

Contacts

Public ContactAmit R Agarwal

Chest Research Foundation

aagarwal@crfindia.com020-49134338

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026